Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

Go back to Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
(NASDAQ: GLSI) Delayed: 16.95 +1.64 (10.71%)
Previous Close $15.31    52 Week High $ 
Open $16.16    52 Week Low $ 
Day High $17.48    P/E N/A 
Day Low $15.54    EPS $ 
Volume 97,446